Scott Dunseth Myers Insider Trading $CASC Cascadian Therapeutics, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Scott Dunseth Myers.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Scott Dunseth Myers. Scott Dunseth Myers is President & CEO in AMAG PHARMACEUTICALS, INC. ($AVM) and Senior Vice President in Euthymics Bioscience Inc ($DOVP) and President and CEO in Oncothyreon Inc. ($ONTY) and Director in SELECTA BIOSCIENCES INC ($SELB) and Director in Harpoon Therapeutics, Inc. ($HARP).

Scott Dunseth Myers in Cascadian Therapeutics, Inc.

Trading Symbol: CASC
Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of Scott Dunseth Myers: President and CEO
Holdings: 0 shares
Latest Transaction: Mar 13 2018

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Scott Dunseth Myers in Cascadian Therapeutics, Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, AVM, CASC, DOVP, HARP, SELB

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Mar 13 2018CASCCascadian Therapeu ...Myers Scott DunsethPresident and CEOOption ExerciseD0.00250,00000
Mar 13 2018CASCCascadian Therapeu ...Myers Scott DunsethPresident and CEOOption ExerciseD0.006,30000
Mar 13 2018CASCCascadian Therapeu ...Myers Scott DunsethPresident and CEOOption ExerciseD0.0015,50000
Mar 13 2018CASCCascadian Therapeu ...Myers Scott DunsethPresident and CEOOption ExerciseD0.0042,00000
Mar 13 2018CASCCascadian Therapeu ...Myers Scott DunsethPresident and CEOOption ExerciseD3.9960,000239,4000
Mar 13 2018CASCCascadian Therapeu ...Myers Scott DunsethPresident and CEOOption ExerciseD4.64190,000881,6000
Mar 13 2018CASCCascadian Therapeu ...Myers Scott DunsethPresident and CEOOption ExerciseD7.08474,8103,361,6550
Mar 13 2018CASCCascadian Therapeu ...Myers Scott DunsethPresident and CEOSellU0.0056,7870056.8 K to 0 (-100.00 %)
Feb 02 2018CASCCascadian Therapeu ...Myers Scott DunsethPresident and CEOOption ExerciseA0.00250,0000250,000
Jan 16 2018CASCCascadian Therapeu ...Myers Scott DunsethPresident and CEOOption ExerciseM0.0010,500031,500
Jan 16 2018CASCCascadian Therapeu ...Myers Scott DunsethPresident and CEOPayment of ExerciseF3.923,42913,44256,78760.2 K to 56.8 K (-5.69 %)
Jan 16 2018CASCCascadian Therapeu ...Myers Scott DunsethPresident and CEOBuyM0.0010,500060,21649.7 K to 60.2 K (+21.12 %)
Nov 13 2017CASCCascadian Therapeu ...Myers Scott DunsethPresident and CEOOption ExerciseA0.006,30006,300
Sep 20 2017CASCCascadian Therapeu ...Myers Scott DunsethPresident and CEOOption ExerciseA0.0015,500015,500
Sep 20 2017CASCCascadian Therapeu ...Myers Scott DunsethPresident and CEOOption ExerciseA3.9960,000239,40060,000
Aug 14 2017CASCCascadian Therapeu ...Myers Scott DunsethPresident and CEOBuyP3.745,50020,54349,71644.2 K to 49.7 K (+12.44 %)
May 16 2017CASCCascadian Therapeu ...Myers Scott DunsethPresident and CEOBuyP4.002,80011,19244,21641.4 K to 44.2 K (+6.76 %)
Apr 04 2017CASCCascadian Therapeu ...Myers Scott DunsethPresident and CEOBuyP4.112,0008,22941,41639.4 K to 41.4 K (+5.07 %)
Mar 21 2017CASCCascadian Therapeu ...Myers Scott DunsethPresident and CEOBuyP3.931,0003,92739,41638.4 K to 39.4 K (+2.60 %)
Jan 31 2017ONTYCascadian Therapeu ...Myers Scott DunsethPresident and CEOBuyP3.7620,50077,03938,41617.9 K to 38.4 K (+114.42 %)
Jan 13 2017ONTYCascadian Therapeu ...Myers Scott DunsethPresident and CEOOption ExerciseA0.0042,000042,000
Jan 13 2017ONTYCascadian Therapeu ...Myers Scott DunsethPresident and CEOOption ExerciseA4.64190,000881,600190,000
Aug 18 2016ONTYCascadian Therapeu ...Myers Scott DunsethPresident and CEOBuyP1.1545,00051,746107,50062.5 K to 107.5 K (+72.00 %)
Jun 28 2016ONTYCascadian Therapeu ...Myers Scott DunsethPresident and CEOBuyP0.8062,50050,00062,5000 to 62.5 K
Apr 06 2016ONTYOncothyreon Inc.Myers Scott DunsethPresident and CEOOption ExerciseA1.182,848,8553,361,6492,848,855

Page:   1

Contact us | Follow us on Twitter